Prognostic value of volumetric metabolic parameter changes determined by during and after radiotherapy‐based 18 F‐FDG PET/CT in stage III non‐small cell lung cancer-Reference-Cited by-同舟云学术

Prognostic value of volumetric metabolic parameter changes determined by during and after radiotherapy‐based 18 F‐FDG PET/CT in stage III non‐small cell lung cancer

Published:2019-03 Issue:3 Volume:35 Page:151-159
ISSN:1607-551X
Container-title:The Kaohsiung Journal of Medical Sciences
language:en
Short-container-title:Kaohsiung J Med Sci

Author:

Chen Helen H. W.¹,Su Wu‐Chou²,Guo How‐Ran³,Lee Bi‐Fang⁴,Chiu Nan‐Tsing⁴

Affiliation:

1. Departments of Radiation OncologyNational Cheng Kung University Hospital, College of Medicine, National Cheng Kung University Tainan Taiwan

2. Internal MedicineNational Cheng Kung University Hospital, College of Medicine, National Cheng Kung University Tainan Taiwan

3. Environmental and Occupational HealthNational Cheng Kung University Hospital, College of Medicine, National Cheng Kung University Tainan Taiwan

4. Nuclear MedicineNational Cheng Kung University Hospital, College of Medicine, National Cheng Kung University Tainan Taiwan

Funder

MOE

Ministry of Science and Technology

Publisher

Wiley

Subject

General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/kjm2.12027

Reference33 articles.

1. The national cancer data base report on lung cancer;Fry WA;Cancer,1996

2. Multimodality approach to management of stage III non‐small cell lung cancer;Scarpaci A;Surg Oncol Clin N Am,2013

3. Phase III comparison of sequential vs concurrent chemoradiation for pts with unresected stage III non‐small cell lung cancer (NSCLC): Report of radiation therapy oncology group (RTOG) 9410;Curran W;Lung Cancer,2000

4. Continuous hyperfractionated accelerated radiotherapy (CHART) versus conventional radiotherapy in non‐small‐cell lung cancer: A randomised multicentre trial;Saunders M;Lancet,1997

5. Radiotherapy alone versus combined chemotherapy and radiotherapy in unresectable non‐small cell lung carcinoma;Le Chevalier T;Lung Cancer,1994

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prognostic Value of Early Fluorodeoxyglucose-Positron Emission Tomography Response Imaging and Peripheral Immunologic Biomarkers: Substudy of a Phase II Trial of Risk-Adaptive Chemoradiation for Unresectable Non-Small Cell Lung Cancer;Advances in Radiation Oncology;2022-03

2. New developments in locally advanced nonsmall cell lung cancer;European Respiratory Review;2021-05-05

3. Relationship Between PET/CT Response and Survival in Patients with Non-Small-Cell Lung Cancer Treated with Definitive Chemoradiotherapy;International Journal of Hematology and Oncology;2021-03-30

4. Prognostic value and peripheral immunologic correlates of early FDG PET response imaging in a phase II trial of risk-adaptive chemoradiation for unresectable non-small cell lung cancer;2021-02-23

5. PET-Based Volumetric Biomarkers for Risk Stratification of Non-Small Cell Lung Cancer Patients;Diagnostics;2021-01-30